Analysts agree that Kenvue's Neutrogena needs a face-lift [Seeking Alpha]
Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (HLN)
Company Research
Source: Seeking Alpha
Both Jefferies and RBC Capital see increased investment in its Neutrogena brand as a positive step that will unlock value for the entire company. But after pandemic-led shortages lured consumers to competing – and cheaper -- brands, RBC Capital's Nik Modi believes these challenges have evolved into more structural problems with the brand, exacerbated by “organizational inefficiencies,” while Jefferies' Keith Devas sees an increase in reinvestment in the brand re-invigorating growth and delivering mid-single-digit EPS growth for the entire company. With a more upbeat outlook for Kenvue ( KVUE ) and the broader skin care & beauty category, Jefferies initiates the stock with a Buy rating and $27 price target, while RBC Capital downgrades Kenvue ( KVUE ) to Sector Perform from Outperform with a $24 price target. “While we acknowledge the company is getting better at expectations management and its segments are performing well, we are struggling to justify any more upside,” RBC Capital
Show less
Read more
Impact Snapshot
Event Time:
HLN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HLN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HLN alerts
High impacting Haleon plc American Depositary Shares (Each representing two Ordinary Shares) news events
Weekly update
A roundup of the hottest topics
HLN
News
- Sensodyne maker Haleon to raise stake in China JV [Yahoo! Finance]Yahoo! Finance
- Haleon plc (NYSE: HLN) had its price target raised by analysts at Morgan Stanley from $9.90 to $10.95. They now have an "overweight" rating on the stock.MarketBeat
- Haleon (LSE:HLN) Eyes Bolt-On M&A and New Product Launches to Drive Growth Despite High Valuation Concerns [Yahoo! Finance]Yahoo! Finance
- Estimating The Fair Value Of Haleon plc (LON:HLN) [Yahoo! Finance]Yahoo! Finance
- Haleon Announces the Launch of Eroxon®, The First and Only FDA Cleared OTC Gel for Erectile Dysfunction, Available for U.S. Preorder Without a Prescription [Yahoo! Finance]Yahoo! Finance
HLN
Sec Filings
- 9/27/24 - Form 6-K
- 9/27/24 - Form 6-K
- 9/26/24 - Form 6-K
- HLN's page on the SEC website